tiprankstipranks
Trending News
More News >
Medicover AB (SE:MCOV.B)
:MCOV.B
Sweden Market
Advertisement

Medicover AB (MCOV.B) Earnings Dates, Call Summary & Reports

Compare
2 Followers

Earnings Data

Report Date
Feb 10, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.44
Last Year’s EPS
0.64
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter with significant revenue and operational growth, particularly in Healthcare and Diagnostic Services. However, there are challenges related to consumer behavior, the strategic exit from Hungary, and short-term impacts in India. Despite these challenges, the overall business model remains robust with positive long-term prospects.
Company Guidance
In the Q3 2025 call, Medicover provided robust guidance with several key metrics indicating strong financial health and strategic progress. The company reported a revenue growth of 12.1%, excluding Hungary, and an EBITDA increase of 32%, with an adjusted margin of 17.2%. Operating cash flows were notably healthy at EUR 98.8 million, marking a 36.7% improvement. The company's leverage ratio has normalized to 3.2, in line with guidance, despite significant acquisitions. Healthcare Services reported a revenue growth of 9.6%, adjusting to 12.4% when excluding Hungary, with steady growth in countries like Romania and Poland. Diagnostic Services demonstrated a revenue increase of 17.8% and an organic growth of 12.4%, with Germany showing resilience amid reforms. The company is on track to exceed its 2025 targets, including an organic growth revenue of EUR 2.2 billion and adjusted organic EBITDA of EUR 350 million. Despite some mild headwinds, including a strike in India, Medicover remains confident in its growth trajectory, buoyed by strategic investments and operational efficiencies.
Strong Revenue Growth
The company reported a 12.1% growth in revenue despite excluding Hungary, with solid performance across multiple countries and segments. EBITDA saw an impressive increase of 32%, and operating cash flows rose by 36.7%.
Healthcare Services Expansion
Healthcare Services revenue grew by 9.6%, adjusted to 12.4% excluding Hungary. The company launched a new hospital in Hyderabad and plans to advance another hospital opening due to strong doctor recruitment.
Diagnostic Services Performance
Diagnostic Services revenue increased by 17.8% with organic growth at 12.4%. There was strong demand in the fee-for-service segment, particularly in Germany, which saw a 5% growth despite reforms.
Operational and Financial Improvements
Medicover achieved margin expansion across all profit measures, normalized leverage to 3.2, improved ROIC, and strong cash flow generation with recurring cash flow at 9.4% of revenue.

Medicover AB (SE:MCOV.B) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SE:MCOV.B Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 10, 2026
2025 (Q4)
1.44 / -
0.636
Nov 05, 2025
2025 (Q3)
1.26 / 1.41
-0.329530.00% (+1.74)
Jul 24, 2025
2025 (Q2)
1.30 / 1.39
0.46202.38% (+0.93)
Apr 29, 2025
2025 (Q1)
0.98 / 1.46
0.449224.39% (+1.01)
Feb 12, 2025
2024 (Q4)
0.45 / 0.64
0.855-25.64% (-0.22)
Oct 30, 2024
2024 (Q3)
0.77 / -0.33
-0.077-328.57% (-0.25)
Jul 25, 2024
2024 (Q2)
0.66 / 0.46
0.40613.51% (+0.05)
Apr 26, 2024
2024 (Q1)
0.33 / 0.45
0.11310.00% (+0.34)
Feb 09, 2024
2023 (Q4)
0.31 / 0.85
0.142500.00% (+0.71)
Nov 03, 2023
2023 (Q3)
0.55 / -0.08
-0.26370.83% (+0.19)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SE:MCOV.B Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
kr243.50kr237.50-2.46%
Jul 24, 2025
kr257.50kr285.00+10.68%
Apr 29, 2025
kr212.00kr231.86+9.37%
Feb 12, 2025
kr208.52kr205.54-1.43%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medicover AB (SE:MCOV.B) report earnings?
Medicover AB (SE:MCOV.B) is schdueled to report earning on Feb 10, 2026, Before Open (Confirmed).
    What is Medicover AB (SE:MCOV.B) earnings time?
    Medicover AB (SE:MCOV.B) earnings time is at Feb 10, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Medicover AB stock?
          The P/E ratio of Medicover AB is N/A.
            What is SE:MCOV.B EPS forecast?
            SE:MCOV.B EPS forecast for the fiscal quarter 2025 (Q4) is 1.44.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis